ORNBVOrion Oyj Class B
78.85EUR-0.25%Mkt Cap: 12.10B $P/E: 18.91

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharm…

Key Statistics

Company
Market Cap12.10B $
Enterprise Value12.11B $
Revenue (TTM)2.24B $
Gross Profit1.32B $
Net Income (TTM)543.80M $
Revenue/Share15.89 USD
Last Price78.85 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4.0K
CountryFI
SectorHealthcare
IndustryDrug Manufacturers - General
ISINFI0009014377
Valuation
P/E (Trailing)18.91
P/E (Forward)16.82
PEG5.73
EV/EBITDA14.03
EV/Revenue5.41
P/S5.40
P/B8.76
EPS (TTM)4.18
EPS (Forward)4.69
52W Range
56.5085% of range82.80
52W High82.80 EUR
52W Low56.50 EUR
Profitability
Gross Margin64.20%
Oper. Margin33.84%
EBITDA Margin38.58%
Profit Margin26.48%
ROE38.95%
ROA24.89%
Growth
Revenue Growth25.20%
Earnings Growth69.50%
Cash Flow & Leverage
Operating CF344.35M $
CapEx (TTM)106.09M $
FCF Margin13.06%
FCF Yield2.41%
Net Debt2.72M $
Net Debt/EBITDA0.00
Balance Sheet
Debt/Equity0.24
Current Ratio2.64
Quick Ratio1.48
Book Value/Sh9.008 EUR
Cash/Share0.9240 EUR
Dividends
Fwd Div Rate1.800 EUR
Trail. Div Rate1.800 EUR
Div. Yield2.28%
5Y Avg Yield3.22%
Payout Ratio41.15%
Ex-Div DateOct 19, 2026
Pay Date
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)76.67 EUR
Upside (mean)-2.8%
Target Range55.00 EUR86.00 EUR
55.00-2.8% to mean86.00
# Analysts6
Ownership
Shares Out.109.49M
Float123.11M
Insiders2.63%
Institutions45.44%
Technical
SMA 5074.24 (+6.2%)
SMA 20068.91 (+14.4%)
Beta0.30
S&P 52W Chg18.16%
Avg Vol (30d)165.78K
Avg Vol (10d)154.21K
Technical Indicators
RSI (14)55.6
MACD1.1555
MACD Signal1.6802
MACD Hist.-0.5247
BB Upper82.63 EUR
BB Middle79.75 EUR
BB Lower76.86 EUR
BB Width7.24%
ATR (14)1.819 EUR
Vol Ratio (20d)0.54x